Literature DB >> 24494716

Hypertension in hemodialysis patients: an opinion-based update.

Tariq Shafi1, Sana Waheed, Philip G Zager.   

Abstract

Hypertension is highly prevalent in hemodialysis patients but its management remains a matter of debate. In this review, we discuss the observational studies on the association of blood pressure with outcomes, measurement of blood pressure in hemodialysis patients and present an opinion-based approach to treating hypertension.
© 2014 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2014        PMID： 24494716      PMCID： PMC3956305          DOI： 10.1111/sdi.12195

Source DB:  PubMed          Journal:  Semin Dial        ISSN： 0894-0959            Impact factor:   3.455


  75 in total

1.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

Authors: 
Journal:  Am J Kidney Dis       Date:  2005-04       Impact factor: 8.860

2.  Intradialytic blood volume monitoring in ambulatory hemodialysis patients: a randomized trial.

Authors:  Donal N Reddan; Lynda Anne Szczech; Vic Hasselblad; Edmund G Lowrie; Robert M Lindsay; Jonathan Himmelfarb; Robert D Toto; John Stivelman; James F Winchester; Linda A Zillman; Robert M Califf; William F Owen
Journal:  J Am Soc Nephrol       Date:  2005-06-01       Impact factor: 10.121

Review 3.  Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases.

Authors:  Patrick Rossignol; Michèle Kessler; Faiez Zannad
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-01       Impact factor: 2.894

4.  Effects of lowering dialysate sodium on carotid artery atherosclerosis and endothelial dysfunction in maintenance hemodialysis patients.

Authors:  Hasan Ali Gümrükçüoğlu; Elif Arı; Aytaç Akyol; Serkan Akdağ; Hakkı Simşek; Musa Sahin; Yılmaz Güneş; Mustafa Tuncer
Journal:  Int Urol Nephrol       Date:  2012-01-14       Impact factor: 2.370

5.  Clinical decision support to improve blood pressure control in hemodialysis patients: a nonrandomized controlled trial.

Authors:  Stephanie Thompson; Brenda Hemmelgarn; Natasha Wiebe; Sumit Majumdar; Scott Klarenbach; Kailash Jindal; Braden Manns; Garth Mortis; Patricia Campbell; Marcello Tonelli
Journal:  J Nephrol       Date:  2012 Nov-Dec       Impact factor: 3.902

6.  Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

Authors:  Bruce M Robinson; Lin Tong; Jinyao Zhang; Robert A Wolfe; David A Goodkin; Roger N Greenwood; Peter G Kerr; Hal Morgenstern; Yun Li; Ronald L Pisoni; Rajiv Saran; Francesca Tentori; Tadao Akizawa; Shunichi Fukuhara; Friedrich K Port
Journal:  Kidney Int       Date:  2012-06-20       Impact factor: 10.612

7.  Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions.

Authors:  Kamyar Kalantar-Zadeh; Ryan D Kilpatrick; Charles J McAllister; Sander Greenland; Joel D Kopple
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

8.  Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? Con position.

Authors:  Matthew R Weir
Journal:  J Am Soc Hypertens       Date:  2012-11-03

9.  The effect of empowerment on the self-efficacy, quality of life and clinical and laboratory indicators of patients treated with hemodialysis: a randomized controlled trial.

Authors:  Marzieh Moattari; Marzieh Ebrahimi; Nasrin Sharifi; Jamshid Rouzbeh
Journal:  Health Qual Life Outcomes       Date:  2012-09-20       Impact factor: 3.186

10.  Expanding the definition and classification of hypertension.

Authors:  Thomas D Giles; Bradford C Berk; Henry R Black; Jay N Cohn; John B Kostis; Joseph L Izzo; Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-09       Impact factor: 3.738
View more
  6 in total

1.  Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study.

Authors:  Tariq Shafi; Philip G Zager; Stephen M Sozio; Morgan E Grams; Bernard G Jaar; Robert H Christenson; L Ebony Boulware; Rulan S Parekh; Neil R Powe; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-04-29       Impact factor: 8.860

2.  Alprostadil for hypertensive nephropathy: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Hongfang Fu; Weiwei Hou; Yang Zhang; Xiaoyu Hu
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  Impact of use of angiotensin II receptor blocker on all-cause mortality in hemodialysis patients: prospective cohort study using a propensity-score analysis.

Authors:  Marenao Tanaka; Tomohisa Yamashita; Masayuki Koyama; Norihito Moniwa; Kohei Ohno; Kaneto Mitsumata; Takahito Itoh; Masato Furuhashi; Hirofumi Ohnishi; Hideaki Yoshida; Kazufumi Tsuchihashi; Tetsuji Miura
Journal:  Clin Exp Nephrol       Date:  2015-10-24       Impact factor: 2.801

4.  Antihypertensive medications and risk of death and hospitalizations in US hemodialysis patients: Evidence from a cohort study to inform hypertension treatment practices.

Authors:  Tariq Shafi; Stephen M Sozio; Jason Luly; Karen J Bandeen-Roche; Wendy L St Peter; Patti L Ephraim; Aidan McDermott; Charles A Herzog; Deidra C Crews; Julia J Scialla; Navdeep Tangri; Dana C Miskulin; Wieneke M Michels; Bernard G Jaar; Philip G Zager; Klemens B Meyer; Albert W Wu; L Ebony Boulware
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 5.  The Impact of Hemodialysis Frequency and Duration on Blood Pressure Management and Quality of Life in End-Stage Renal Disease Patients.

Authors:  Mohammad Ali Shafiee; Pouyan Chamanian; Pouyan Shaker; Yasmin Shahideh; Behrooz Broumand
Journal:  Healthcare (Basel)       Date:  2017-09-02

6.  The prevalence, relative risk factors and MTHFR C677T genotype of H type hypertension of the elderly hypertensives in Shanghai, China: a cross-section study : Prevalence of H type hypertension.

Authors:  Bin Hong; Zhao-Qiang Cui; Jun-Bo Ge; Xiao-Lin Qian; Hong Cao; Jun Zhang; Zhi-Hui Gu; Wei-Qin Tang; Lei Shen; Jia-Lu Hu; Zhi-Feng Yao; Lei Zhang; Min-Na Tang; Xu-Cheng Lv; Jun Zhou; Xue-Juan Jin
Journal:  BMC Cardiovasc Disord       Date:  2021-08-04       Impact factor: 2.298
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.